<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-715
Date of Submission: 2024-09-26

This report was submitted by a Nurse from Johnson-Simmons Medical Center concerning patient ANON-PX-8858. The subject is a 60-year-old female with a significant medical history including seasonal allergies, chronic kidney disease, atrial fibrillation, osteoarthritis. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Atorvastatin (Statin) administered via the Intravenous route at a dosage of 385mg, initiated on 2024-08-26 for Hypercholesterolemia with the course ongoing; Amoxicillin administered via the Subcutaneous route at a dosage of 38mg, initiated on 2024-08-26 for Bacterial infection with the course ongoing.

On approximately 2024-09-04, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Nausea, Somnolence. The Nausea was classified as Severe in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Fatal'. The Somnolence was classified as Life-threatening in severity. This necessitated clinical intervention. The documented action was: Prescribed them and advised car. The current patient status regarding this symptom is 'Recovering'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Not applicable'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: List single top which yourself third move. Ground always recently wish. To personal so very.</data>
report_id: ADR-2024-715
report_date: '2024-09-26'
patient_details:
  patient_id: ANON-PX-8858
  gender: Female
  relevant_history:
  - seasonal allergies
  - chronic kidney disease
  - atrial fibrillation
  - osteoarthritis
  age_at_reaction: 60
suspected_drugs:
- drug_name: Atorvastatin
  dosage: 385mg
  route_of_administration: Intravenous
  start_date: '2024-08-26'
  indication_for_use: Hypercholesterolemia
  drug_class: Statin
- drug_name: Amoxicillin
  dosage: 38mg
  route_of_administration: Subcutaneous
  start_date: '2024-08-26'
  indication_for_use: Bacterial infection
adverse_reactions:
- symptom_name: Nausea
  onset_date: '2024-09-04'
  severity: Severe
  outcome: Fatal
  intervention_required: false
- symptom_name: Somnolence
  onset_date: '2024-09-04'
  severity: Life-threatening
  outcome: Recovering
  intervention_required: true
  intervention_details: Prescribed them and advised car.
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Not applicable
reporting_facility: Johnson-Simmons Medical Center
reporter_type: Nurse
notes: List single top which yourself third move. Ground always recently wish. To
  personal so very.
